Jeffrey Robert Ajer Insider Trading $BMRN BIOMARIN PHARMACEUTICAL INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Jeffrey Robert Ajer.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Jeffrey Robert Ajer. Jeffrey Robert Ajer is Director in NEKTAR THERAPEUTICS ($NKTR) and EVP, Chief Commercial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and SVP, Chief Commercial Of in BIOMARIN PHARMACEUTICAL INC ($BMRN) and SVP, Chief Commercial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN).

Jeffrey Robert Ajer in BIOMARIN PHARMACEUTICAL INC

Trading Symbol: BMRN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey Robert Ajer: EVP, Chief Commercial Officer, SVP, Chief Commercial Officer, SVP, Chief Commercial Of
Holdings: 58,250 shares
Current Value: $5,179,008
Latest Transaction: Apr 09 2021
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Jeffrey Robert Ajer in BIOMARIN PHARMACEUTICAL INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, BMRN, NKTR

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 09 2021	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	78.81	1,537	121,131	58,250	59.8 K to 58.3 K (-2.57 %)
Apr 01 2021	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	74.79	1,652	123,553	59,787	61.4 K to 59.8 K (-2.69 %)
Mar 26 2021	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	76.30	1,181	90,110	61,439	62.6 K to 61.4 K (-1.89 %)
Mar 26 2021	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	76.30	1,181	90,110	61,439	62.6 K to 61.4 K (-1.89 %)
Mar 23 2021	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	78.52	1,513	118,801	62,620	64.1 K to 62.6 K (-2.36 %)
Mar 19 2021	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	77.99	1,308	102,011	64,133	65.4 K to 64.1 K (-2.00 %)
Mar 19 2021	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	77.99	1,308	102,011	64,133	65.4 K to 64.1 K (-2.00 %)
Mar 17 2021	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	A	78.39	26,400	2,069,496	26,400
Mar 17 2021	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	77.21	1,287	99,369	65,441	66.7 K to 65.4 K (-1.93 %)
Mar 17 2021	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	78.39	5,273	413,350	66,728	72 K to 66.7 K (-7.32 %)
Mar 17 2021	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	0.00	10,720	0	72,001	61.3 K to 72 K (+17.49 %)
Oct 15 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	79.91	2,121	169,489	61,281	63.4 K to 61.3 K (-3.35 %)
Jun 23 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	M	63.10	15,000	946,500	15,700
Jun 23 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	124.00	15,000	1,860,000	63,402	78.4 K to 63.4 K (-19.13 %)
Jun 23 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Buy	M	63.10	15,000	946,500	78,402	63.4 K to 78.4 K (+23.66 %)
Jun 23 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	62.59	338	21,154	63,402	63.1 K to 63.4 K (+0.54 %)
Apr 09 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	79.98	2,407	192,512	63,064	65.5 K to 63.1 K (-3.68 %)
Apr 09 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	79.98	2,407	192,512	63,064	65.5 K to 63.1 K (-3.68 %)
Apr 02 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	82.00	1,537	126,034	65,471	67 K to 65.5 K (-2.29 %)
Mar 26 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	78.47	1,618	126,964	67,008	68.6 K to 67 K (-2.36 %)
Mar 26 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	74.36	2,041	151,769	68,626	70.7 K to 68.6 K (-2.89 %)
Mar 24 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	73.05	3,599	262,907	70,667	74.3 K to 70.7 K (-4.85 %)
Mar 17 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	A	73.82	29,590	2,184,334	29,590
Mar 17 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	0.00	10,380	0	74,266	63.9 K to 74.3 K (+16.25 %)
Mar 17 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	84.50	7,644	645,918	63,886	71.5 K to 63.9 K (-10.69 %)
Mar 04 2020	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	0.00	9,586	0	71,530	61.9 K to 71.5 K (+15.48 %)
Jun 07 2019	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	68.78	309	21,254	61,994	61.7 K to 62 K (+0.50 %)
Jun 06 2019	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	0.00	14,160	0	61,635	47.5 K to 61.6 K (+29.83 %)
Mar 27 2019	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	89.18	3,656	326,025	47,475	51.1 K to 47.5 K (-7.15 %)
Mar 26 2019	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	88.05	3,598	316,804	51,131	54.7 K to 51.1 K (-6.57 %)
Mar 25 2019	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	90.47	1,930	174,614	54,729	56.7 K to 54.7 K (-3.41 %)
Mar 25 2019	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	89.62	2,589	232,020	56,659	59.2 K to 56.7 K (-4.37 %)
Mar 21 2019	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	93.07	3,728	346,965	59,248	63 K to 59.2 K (-5.92 %)
Mar 19 2019	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	A	94.53	23,450	2,216,729	23,450
Mar 19 2019	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	0.00	9,370	0	62,976	53.6 K to 63 K (+17.48 %)
Mar 19 2019	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	94.53	7,169	677,686	53,606	60.8 K to 53.6 K (-11.80 %)
Mar 05 2019	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	94.76	917	86,895	60,775	61.7 K to 60.8 K (-1.49 %)
Mar 05 2019	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	0.00	12,557	0	61,692	49.1 K to 61.7 K (+25.56 %)
Nov 16 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	M	63.10	9,000	567,900	30,700
Nov 16 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	94.35	600	56,611	49,135	49.7 K to 49.1 K (-1.21 %)
Nov 16 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	93.81	799	74,957	49,735	50.5 K to 49.7 K (-1.58 %)
Nov 16 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	92.21	2,400	221,297	50,534	52.9 K to 50.5 K (-4.53 %)
Nov 16 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	91.62	5,201	476,494	52,934	58.1 K to 52.9 K (-8.95 %)
Nov 16 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Buy	M	63.10	9,000	567,900	58,135	49.1 K to 58.1 K (+18.32 %)
Oct 05 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	98.98	1,000	98,985	49,135	50.1 K to 49.1 K (-1.99 %)
Jun 13 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	90.31	1,436	129,685	50,135	51.6 K to 50.1 K (-2.78 %)
Jun 06 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	92.07	1,414	130,187	51,571	53 K to 51.6 K (-2.67 %)
May 09 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	85.96	309	26,562	52,914	53.2 K to 52.9 K (-0.58 %)
May 09 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	68.78	309	21,254	53,223	52.9 K to 53.2 K (+0.58 %)
Apr 03 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	80.12	2,119	169,774	52,914	55 K to 52.9 K (-3.85 %)
Mar 30 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	79.69	1,537	122,484	55,033	56.6 K to 55 K (-2.72 %)
Mar 26 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	81.36	3,583	291,513	56,570	60.2 K to 56.6 K (-5.96 %)
Mar 23 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	83.90	4,368	366,475	60,153	64.5 K to 60.2 K (-6.77 %)
Mar 19 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	A	83.57	41,040	3,429,713	41,040
Mar 19 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	0.00	12,840	0	64,521	51.7 K to 64.5 K (+24.84 %)
Mar 19 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	83.57	3,651	305,114	51,681	55.3 K to 51.7 K (-6.60 %)
Mar 13 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	82.39	2,972	244,863	55,332	58.3 K to 55.3 K (-5.10 %)
Mar 06 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	79.86	1,614	128,894	58,304	59.9 K to 58.3 K (-2.69 %)
Feb 28 2018	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	0.00	12,529	0	59,918	47.4 K to 59.9 K (+26.44 %)
Sep 26 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	M	37.46	2,166	81,138	0
Sep 26 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	M	37.46	1,355	50,758	2,166
Sep 26 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	95.00	2,166	205,770	47,944	50.1 K to 47.9 K (-4.32 %)
Sep 26 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Buy	M	37.46	2,166	81,138	50,110	47.9 K to 50.1 K (+4.52 %)
Sep 26 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	95.00	1,355	128,725	47,944	49.3 K to 47.9 K (-2.75 %)
Sep 26 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Buy	M	37.46	1,355	50,758	49,299	47.9 K to 49.3 K (+2.83 %)
Jun 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	89.61	1,004	89,968	47,944	48.9 K to 47.9 K (-2.05 %)
Jun 06 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	90.72	1,488	134,991	48,948	50.4 K to 48.9 K (-2.95 %)
May 17 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	91.50	1,096	100,284	50,436	51.5 K to 50.4 K (-2.13 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	M	38.59	3,498	134,988	0
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	M	28.23	988	27,891	0
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	99.00	3,498	346,302	51,532	55 K to 51.5 K (-6.36 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Buy	M	38.59	3,498	134,988	55,030	51.5 K to 55 K (+6.79 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	99.00	988	97,812	51,532	52.5 K to 51.5 K (-1.88 %)
May 09 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Buy	M	28.23	988	27,891	52,520	51.5 K to 52.5 K (+1.92 %)
May 04 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	96.74	302	29,215	51,532	51.8 K to 51.5 K (-0.58 %)
May 04 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	70.30	302	21,232	51,834	51.5 K to 51.8 K (+0.59 %)
Mar 31 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	89.15	3,890	346,794	51,532	55.4 K to 51.5 K (-7.02 %)
Mar 24 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	A	87.42	39,480	3,451,342	39,480
Mar 24 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	0.00	12,200	0	55,422	43.2 K to 55.4 K (+28.23 %)
Mar 17 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	92.50	3,288	304,140	43,222	46.5 K to 43.2 K (-7.07 %)
Mar 08 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	90.56	5,000	452,800	46,510	51.5 K to 46.5 K (-9.71 %)
Mar 07 2017	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	93.95	1,749	164,319	51,510	53.3 K to 51.5 K (-3.28 %)
Sep 29 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	95.61	18,467	1,765,648	41,342	59.8 K to 41.3 K (-30.88 %)
Jun 07 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	90.00	1,488	133,920	59,809	61.3 K to 59.8 K (-2.43 %)
May 17 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	82.71	1,096	90,650	61,297	62.4 K to 61.3 K (-1.76 %)
May 12 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Payment of Exercise	F	80.80	679	54,863	62,393	63.1 K to 62.4 K (-1.08 %)
May 04 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Sell	S	86.03	415	35,701	63,072	63.5 K to 63.1 K (-0.65 %)
May 04 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	51.26	415	21,275	63,487	63.1 K to 63.5 K (+0.66 %)
Mar 17 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Option Exercise	A	83.43	36,280	3,026,840	36,280
Mar 17 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	EVP, Chief Commerci ...	Grant	A	0.00	16,190	0	63,072	46.9 K to 63.1 K (+34.53 %)
Mar 07 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	88.42	1,255	110,970	46,882	48.1 K to 46.9 K (-2.61 %)
Mar 07 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Payment of Exercise	F	89.57	2,395	214,520	48,137	50.5 K to 48.1 K (-4.74 %)
Mar 02 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Payment of Exercise	F	81.87	17,656	1,445,497	50,532	68.2 K to 50.5 K (-25.89 %)
Feb 26 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Grant	A	0.00	5,883	0	68,188	62.3 K to 68.2 K (+9.44 %)
Feb 26 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Grant	A	0.00	19,840	0	62,305	42.5 K to 62.3 K (+46.72 %)
Feb 26 2016	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Grant	A	0.00	6,860	0	42,465	35.6 K to 42.5 K (+19.27 %)
Nov 06 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	117.56	26	3,057	35,605	35.6 K to 35.6 K (-0.07 %)
Nov 06 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Grant	A	57.26	26	1,489	35,631	35.6 K to 35.6 K (+0.07 %)
Jul 22 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	M	63.10	3,000	189,300	39,700
Jul 22 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	150.00	3,000	450,000	35,605	38.6 K to 35.6 K (-7.77 %)
Jul 22 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Buy	M	63.10	3,000	189,300	38,605	35.6 K to 38.6 K (+8.43 %)
Jun 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	122.35	1,362	166,646	35,605	37 K to 35.6 K (-3.68 %)
Jun 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Payment of Exercise	F	120.46	1,488	179,244	36,967	38.5 K to 37 K (-3.87 %)
Jun 03 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	123.76	377	46,657	38,455	38.8 K to 38.5 K (-0.97 %)
Jun 03 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Payment of Exercise	F	125.57	413	51,860	38,832	39.2 K to 38.8 K (-1.05 %)
May 26 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	126.55	1,625	205,647	39,245	40.9 K to 39.2 K (-3.98 %)
May 19 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Payment of Exercise	F	122.78	1,096	134,567	40,870	42 K to 40.9 K (-2.61 %)
May 12 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Payment of Exercise	F	121.66	679	82,607	41,966	42.6 K to 42 K (-1.59 %)
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	M	37.46	8,671	324,816	2,166
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	M	37.46	808	30,268	1,355
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	M	28.23	5,258	148,433	0
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	M	28.23	2,642	74,584	978
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	M	21.51	3,125	67,219	0
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	M	21.51	625	13,444	0
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	M	38.59	12,502	482,452	0
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	119.20	388	46,248	42,645	43 K to 42.6 K (-0.90 %)
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	119.14	33,631	4,006,794	43,033	76.7 K to 43 K (-43.87 %)
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Buy	M	37.46	8,671	324,816	76,664	68 K to 76.7 K (+12.75 %)
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Buy	M	37.46	808	30,268	67,993	67.2 K to 68 K (+1.20 %)
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Buy	M	28.23	5,258	148,433	67,185	61.9 K to 67.2 K (+8.49 %)
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Buy	M	28.23	2,642	74,584	61,927	59.3 K to 61.9 K (+4.46 %)
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Buy	M	21.51	3,125	67,219	59,285	56.2 K to 59.3 K (+5.56 %)
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Buy	M	21.51	625	13,444	56,160	55.5 K to 56.2 K (+1.13 %)
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Buy	M	38.59	12,502	482,452	55,535	43 K to 55.5 K (+29.05 %)
May 08 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Grant	A	51.26	943	48,341	43,033	42.1 K to 43 K (+2.24 %)
Mar 05 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	A	108.36	23,900	2,589,804	23,900
Mar 05 2015	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Grant	A	0.00	10,500	0	42,090	31.6 K to 42.1 K (+33.24 %)
Dec 05 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	M	38.59	12,000	463,080	12,502
Dec 05 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	91.01	12,000	1,092,161	31,590	43.6 K to 31.6 K (-27.53 %)
Dec 05 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Buy	M	38.59	12,000	463,080	43,590	31.6 K to 43.6 K (+37.99 %)
Nov 05 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	83.54	47	3,926	31,590	31.6 K to 31.6 K (-0.15 %)
Nov 05 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Grant	A	31.26	47	1,469	31,637	31.6 K to 31.6 K (+0.15 %)
Jun 06 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	A	63.10	42,700	2,694,370	42,700
Jun 06 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Grant	A	0.00	11,400	0	31,590	20.2 K to 31.6 K (+56.46 %)
Jun 03 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	57.83	377	21,804	20,190	20.6 K to 20.2 K (-1.83 %)
Jun 02 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Payment of Exercise	F	57.96	413	23,937	20,567	21 K to 20.6 K (-1.97 %)
May 19 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	56.91	1,004	57,136	20,980	22 K to 21 K (-4.57 %)
May 16 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Payment of Exercise	F	57.44	1,096	62,954	21,984	23.1 K to 22 K (-4.75 %)
May 14 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	58.18	478	27,809	23,080	23.6 K to 23.1 K (-2.03 %)
May 14 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Payment of Exercise	F	59.30	522	30,955	23,558	24.1 K to 23.6 K (-2.17 %)
May 13 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	57.96	621	35,992	24,080	24.7 K to 24.1 K (-2.51 %)
May 12 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Payment of Exercise	F	56.78	679	38,554	24,701	25.4 K to 24.7 K (-2.68 %)
May 05 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	59.55	666	39,661	25,380	26 K to 25.4 K (-2.56 %)
May 05 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Grant	A	29.70	666	19,780	26,046	25.4 K to 26 K (+2.62 %)
Mar 10 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	M	28.23	14,812	418,143	5,258
Mar 10 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	M	21.51	2,558	55,023	3,125
Mar 10 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Sell	S	78.63	17,370	1,365,831	25,380	42.8 K to 25.4 K (-40.63 %)
Mar 10 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Buy	M	28.23	14,812	418,143	42,750	27.9 K to 42.8 K (+53.02 %)
Mar 10 2014	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Buy	M	21.51	2,558	55,023	27,938	25.4 K to 27.9 K (+10.08 %)
Dec 11 2013	BMRN	BIOMARIN PHARMACEU ...	Ajer Jeffrey Robert	SVP, Chief Commerci ...	Option Exercise	M	21.51	9,192	197,720	625

Page: 1 2 next >